Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial-Reference-Cited by-同舟云学术

Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial

Published:2013-12-27 Issue:1 Volume:7 Page:91-100
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Schulz Stefanie, ,Angiolillo Dominick J.,Antoniucci David,Bernlochner Isabell,Hamm Christian,Jaitner Juliane,Laugwitz Karl-Ludwig,Mayer Katharina,von Merzljak Barbara,Morath Tanja,Neumann Franz-Josef,Richardt Gert,Ruf Judith,Schömig Gisela,Schühlen Helmut,Schunkert Heribert,Kastrati Adnan

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12265-013-9527-3.pdf

Reference34 articles.

1. Schomig, A., Neumann, F. J., Kastrati, A., et al. (1996). A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. The New England Journal of Medicine, 334, 1084–1089.

2. Hamm, C. W., Bassand, J. P., Agewall, S., et al. (2011). ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 32, 2999–3054.

3. Task Force on the management of STseamiotESoC, Steg, P. G., James, S. K., et al. (2012). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 33, 2569–2619.

4. Kushner, F. G., Hand, M., Smith, S. C., Jr., et al. (2009). 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 54, 2205–2241.

5. Levine, G. N., Bates, E. R., Blankenship, J. C., et al. (2011). 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Journal of the American College of Cardiology, 58, e44–e122.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel;Clinical Research in Cardiology;2024-05-13

2. Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials;Frontiers in Cardiovascular Medicine;2023-01-12

3. Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial;Journal of the American Heart Association;2022-12-20

4. Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes;Thrombosis and Haemostasis;2022-11-28

5. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk;Circulation: Cardiovascular Interventions;2022-10